| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.46 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |